How AI Enables Unified Patient Journeys for Faster, More Accurate Rare Disease Diagnoses

Every year shaved off the diagnostic odyssey means fewer irreversible complications, fewer misdiagnoses, and fewer clinicians and families left wondering what they missed. A unified, longitudinal approach doesn’t just speed up diagnosis — it changes, and in some cases saves, lives. The post How AI Enables Unified Patient Journeys for Faster, More Accurate Rare Disease…

Read More

Apella Lands $80M Series B to Optimize Hospital ORs

Apella raised an $80 million Series B funding round to expand its AI-powered platform designed to help hospitals optimize their operating rooms. The startup’s tool promises to boost surgical volume, reduce clinician burnout and improve patient access without adding new staff or facilities. The post Apella Lands $80M Series B to Optimize Hospital ORs appeared…

Read More

Aktis Has First Biotech IPO of 2026, Raising $318M to Expand the Reach of Radiopharmaceuticals

Aktis Oncology’s IPO will support a pipeline of “miniprotein” radioconjugates that could offer advantages over other targeted radiation cancer treatments. In addition to its internal pipeline, Aktis has a discovery partnership with Eli Lilly. The post Aktis Has First Biotech IPO of 2026, Raising $318M to Expand the Reach of Radiopharmaceuticals appeared first on MedCity…

Read More